Experimental study of ethanolic extract of brown algae Nizimuddinia zanardinii on liver histopathological injury induced by bile duct ligation inrats

Subject Areas : Journal of Comparative Pathobiology

مدارا  Nasiri ¹ (Department of Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran)
, M  Ale-Ebrahim ² (Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran)
, R  Hajikhani ³ (Department of Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.)
, P  Mortazavi ⁴ (Department of Pathology, Faculty of Specialized Veterinary, Science and Research Branch, Islamic Azad University, Tehran, Iran)

Received: 2021-11-03 Accepted : 2021-11-03 Published : 2021-05-22

Keywords: Bile duct ligation, Cholestasis, Liver fibrosis, Brown algae, Nizimuddiniazanardinii,

Abstract :

liver fibrosis has been recognized as a cause of morbidity and mortality in humans. The oxidative stress in cholestatic­liver disease serves as a link between hepatic injury and liver­fibrosis. Therefore, any agent that has the capacity of normalizing the oxidative damage, would be able to decrease fibrosis in a cholestatic liver. The brown Algae Nizimuddiniazanardiniiis one of the natural resources in the marine ecosystem which contains biologically active­compoundsand it's anti-inflammatory, anti-cancer, anti-fungal and antioxidant effects are known.The aim of the present study was the evaluation of the effect of ethanolic­extract of brown­algaeNizimuddiniazanardinii on liver­fibrosis induced by bile­duct­ligation (BDL) in male­rats. 54 male rats were randomly classified in nine groups (n=6): control group (intact rats), sham group (laparatomy without BDL),Nizimuddinia extract control groups (50,­100 or 200­mg/kg). BDL group, experimental treatment groups (BDL rats+­50,­100 or 200­mg/kg Nizimuddinia). BDL increased the serum­levels of aspartate­aminotransferase, alanine­aminotransferase, alkaline­phosphatase, total­bilirubin, cholesterol and triglyceride, whereas it reduced the levels of antioxidant­enzymes, superoxide­dismutase and catalase in the liver and also reduced the serumic levels of albumin and total protein. Treatment of BDL rats with Nizimuddiniazanardiniiextract attenuated these changes. As determined by Masson’s trichrome staining, BDL markedly induced the liver­fibrosis. These alterations were also significantly attenuated by Nizimuddiniazanardiniiadministration.  The results of this study indicate the hepatoprotective and antifibrotic effect of Nizimuddinia­zanardiniiin the cholestatic liver. The antifibrotic effect of this brown algea likely due to the antioxidative and free­radical scavenging effects of it.

References:

1. Ale Ebrahim M, Eidi A, Mortazavi P, Tavangar SM, Minai Tehrani D. The evaluation of sodium molybdate effect on liver fibrosis in a rat model of bile duct ligation. J. Comp. Pathol. 2014; 11(4):1421-28.


2. Greim H, Trülzsch D, Czygan P, Rudick J, Hutterer F, Schaffner F and Popper H. Mechanism of cholestasis: 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology. 1972; 63(5):846-50.


3. Mohammadian Z, Eidi A, Mortazavi P, Tavangar SM, Asghari A. Effect of folic acid in cholestatic hepatic fibrosis induced by bile duct ligation model in rat. J Comp Pathol. 2015; 2(49):1627-36.


4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, and Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5): 431-35.


5. Dillon S and Tobias JD. Ondansetron to treat pruritus due to cholestatic jaundice. J Pediatr Pharmacol Ther. 2013; 18(3): 241-346.


6. Silva G, Pereira RB, Valentão P, Andrade PB and Sousa C. Distinct fatty

acid profile of ten brown macroalgae. Rev Bras Farmacogn. 2013; 23(4): 608-13.

7. Mohammadian E, Shabanpoor B, Kordjazi M. Effect of Nizimuddinia zanardini aqueous extract against human pathogenic microbes and evaluating its antioxidant activity. J. Mar. Biol. 2019; 40(10):75-82.


8. Nomura M, Kamogawa H, Susanto E, Kawagoe C, Yasui H, Saga N, Hosokawa M, Miyashita K. Seasonal variations of total lipids, fatty acid composition, and fucoxanthin contents of Sargassumhorneri (Turner) and Cystoseirahakodatensis (Yendo) from the northern seashore of Japan.           J. Appl. Phycol. 2013; 25(4):1159-69.

9. Salehi P, Sonboli A, Eftekhar F, Nejad-Ebrahimi S, Yousefzadi M. Essential Oil Composition, Antibacterial and Antioxidant Activity of the Oil and Various Extracts of Ziziphoraclinopodioides subsp. rigida (B OISS.) R ECH. f. from Iran. Biol. Pharm. Bull. 2005; 28(10): 1892-96.


10. Uchinami H, Seki E, Brenner DA, D'armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology. 2006; 44(2): 420-29.


11. Moss DW. Clinical enzymology. Nature. 1971; 233(5320): 505-505.


12. Sant'Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant. 2011; 20(3):441-53.


13. Koohsari M, Hosseinizadeh SMJ, Valipour MA. Review of Protective Effect of Natural Products Against Carbon Tetrachloride-induced Liver Damage. Clin Exc. 2018; 7(4):13-27.


14. Lin SY, Wang YY, Chen WY, Liao SL, Chou ST, Yang CP, et al. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats. Food Chem Toxicol. 2017; 108: 214-23.


15. Ale-Ebrahim M, Eidi A, Mortazavi P, Tavangar SM, Tehrani DM. Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation. J Trace Elem Med Biol. 2015; 29: 242-48.


16. Tayyar AT, Kozalı S, YetkinYildirim G, Karakus R, Yuksel IT, Erel O, Neselioglu S, Eroglu M. Role of ischemia-modified albumin in the evaluation of oxidative stress in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2019; 32(22):3836-40.


17. Orellana M, Rodrigo R, Thielemann L, Guajardo V. Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comp Biochem Physiol C Toxicol Pharmacol. 2000; 126(2): 105-11.


18. Cralle LJ, Cralley LV, Bus JB. Patty’s industrial toxicology. 3rd ed. NJ: Wiley Interscience; 1981.


19. Duan XJ, Zhang WW, Li XM, Wang BG. Evaluation of antioxidant property of extract and fractions obtained from a red alga, Polysiphoniaurceolata. Food Chem. 2006; 95(1):37-43.


20. Cox S, Abu-Ghannam N, Gupta S. An assessment of the antioxidant and antimicrobial activity of six species of edible Irish seaweeds. Int. Food Res. J. 2010; 17(1): 205-20.


21. Fariman GA, Shastan SJ, Zahedi MM. Seasonal variation of total lipid, fatty acids, fucoxanthin content, and antioxidant properties of two tropical brown algae (Nizamuddiniazanardinii and Cystoseiraindica) from Iran. J. Appl. Phycol. 2016; 28(2):1323-31.